ADHD medication linked to slightly increased risk of heart rhythm problemsJune 01, 2016
Use of methylphenidate in children and young people with ADHD is associated with a slightly increased risk of abnormal heart rhythm (arrhythmia) shortly after the start of treatment, suggests research published by The BMJ today.
Though the absolute risk is likely to be low, the researchers say the benefits of methylphenidate "should be carefully weighed against the potential cardiovascular risks of these drugs in children and adolescents."
Methylphenidate is a central nervous system stimulant used to treat attention deficit hyperactivity disorder (ADHD), and narcolepsy. It is sold under various trade names, Ritalin being one of the most commonly known.
The cardiac safety of stimulants, which are known to slightly raise blood pressure and accelerate the heart rate, has been hotly debated, but the evidence is conflicting.
So a team of researchers based in Australia, Canada and South Korea set out to measure the cardiac safety of methylphenidate in children and young people with ADHD.
Using the South Korea National Health Insurance Database, they extracted data on 1,224 cardiac events from a population of 114,647 children and young people aged 17 or younger and newly treated with methylphenidate at any time from 2008 to 2011.
Cardiac events included heart rhythm problems (arrhythmias), high blood pressure (hypertension), heart attacks (myocardial infarction), ischemic stroke, and heart failure.
Cases of arrhythmia were statistically significantly more likely to have occurred during the first two months of use compared with periods of non-use, and risk was highest in the first three days of use.
The risk was more pronounced in children with existing congenital heart disease.
No significant risk of myocardial infarction was observed, though risk increased after the first week of treatment and remained raised for the first two months of continuous treatment.
No increased risk was observed for hypertension, ischemic stroke, or heart failure.
The authors point out that this is an observational study so no firm conclusions can be drawn about cause and effect - and that their findings should be interpreted with caution. However, the results prompt them to suggest that methylphenidate use might "trigger" the occurrence of arrhythmia in individual patients.
"Methylphenidate exposure in children and young people with diagnosis of ADHD is associated with arrhythmia and potentially with myocardial infarction in specific time periods of use," they write. "With the increased use of drugs for ADHD globally, the benefits of methylphenidate should be carefully weighed against the potential cardiovascular risks of these drugs in children and adolescents."
In a linked editorial, John Jackson, a research fellow at Harvard School of Public Health in Boston, says it is difficult to describe the absolute risk in this type of study, but in the average child, the risk of serious cardiovascular events is extremely small (3 per 100,000 per year) and any absolute increase associated with methylphenidate is also likely to be small.
And he points out that regulatory labeling and treatment guidelines for stimulants recommend caution using these drugs in children with personal or familial history of cardiovascular disease and call for routine monitoring of blood pressure.
"This study underscores the need to consider the severity of ADHD symptoms and the option of non-stimulants for children with high cardiovascular risk and to closely monitor patients for whom stimulants are critical for their wellbeing and development," he concludes.
Related Methylphenidate Current Events and Methylphenidate News Articles
Bone density lower with use of ADHD stimulant medicine
Children and teenagers who take stimulant drugs to treat attention-deficit hyperactivity disorder (ADHD) may have lower bone density than their peers who do not take these medications, a new study finds.
Adderall misuse rising among young adults
While the number of prescriptions for the stimulant Adderall has remained unchanged among young adults, misuse and emergency room visits related to the drug have risen dramatically in this group, new Johns Hopkins Bloomberg School of Public Health research suggests.
Children who take ADHD medicines have trouble sleeping, new study shows
Stimulant medications for attention-deficit/hyperactivity disorder (ADHD) cause sleep problems among the children who take them, a new study from the University of Nebraska-Lincoln concludes.
Illicit drug use may affect sexual function in men
In a study of 1159 males who illicitly used amphetamines, half of participants said drug use had no impact on their sexual functions, while the other half reported impacts such as reduced erectile rigidity and sexual satisfaction, enhanced orgasmic intensity, and delayed ejaculation.
'Darting' mice may hold clues to ADHD, autism and bipolar disorder
A darting mouse may hold an important clue in the development of Attention Deficit Hyperactivity Disorder (ADHD), autism and bipolar disorder, according to a study by a Vanderbilt University-led research team recently published in the Proceedings of the National Academy of Sciences.
Involuntary Eye Movement a Foolproof Indication for ADHD Diagnosis
Attention Deficit Hyperactivity Disorder (ADHD) is the most commonly diagnosed - and misdiagnosed - behavioral disorder in children in America, according to the Centers for Disease Control and Prevention.
Stimulation of brain region restores consciousness to animals under general anesthesia
Stimulating one of two dopamine-producing regions in the brain was able to arouse animals receiving general anesthesia with either isoflurane or propofol.
Major dopamine system helps restore consciousness after general anesthesia, study finds
Researchers may be one step closer to better understanding how anesthesia works.
ADHD Drug May Help Preserve Our Self-Control Resources
Methylphenidate, also known as Ritalin, may prevent the depletion of self-control, according to research published in Psychological Science, a journal of the Association for Psychological Science.
Drug residues in Swedish sewage water
Chemists at Umeå University have been able to trace narcotics substances and prescription drugs in measurements of wastewater from 33 Swedish sewage treatment plants. Cocaine, amphetamine, and methamphetamine, in measurable concentrations, were found in a total of half of the locations.
More Methylphenidate Current Events and Methylphenidate News Articles